Migdal Insurance & Financial Holdings Ltd. Haemonetics Corp Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 01, 2019	SELL	$83.25 - $102.12 $221,611 - $271,843	-2,662 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$90.66 - $116.63 $241,336 - $310,469	2,662 New	2,662 $266,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$467 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$405 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$348 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$329 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$316 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account